Profile for Novo Nordisk A/S (NVO)

$ 62.79   -0.61 (-0.96%) Volume: 1.32m 4:10 PM EDT 27-May-2020
After Hours:  $ 62.79 0.00 (0.00%) Volume: 1.36k 4:14 PM EDT 27-May-2020
Business Description:
Novo Nordisk A/S is a healthcare company. It is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The company's business segments include, diabetes and obesity care, and biopharmaceuticals.
Address: Novo Alle 1, Bagsvaerd, DNK, DK-2880
Telephone: +45 44448888 Website:
Facsimile: N/A Email: [email protected]
CEO: Lars Fruergaard Jorgensen
Employees: 43,730 Market Cap: 146.67b
Issue Type: CS
Auditor: PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab
Last Audit: Unqualified Opinion with Explanation
Indices: N/A
Industry Classifications
Sector: Healthcare CIK: 353278
Industry: Biotechnology
Sub-Industry:    Biotechnology
SIC: Pharmaceutical Preparations (2834),    Biological Products, Except Diagnostic Substances (2836)